Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq

Retension Pharmaceuticals prices IPO at $12 per share

Investing.com · News 17m ago

Japanese Market Significantly Lower

NASDAQ · Markets 20m ago

TRexBio prices IPO at $14 per share, expects $116.7M

Investing.com · News 21m ago

Lumentum CEO: Opto-Parts Capacity Sold Out to 2029

Bloomberg · Markets Video 30m ago

Euro skids toward fifth weekly fall but selling pressure slows

Investing.com · News 45m ago

U.S. East Asian envoy says investors are overpricing Taiwan risk

CNBC · Markets 47m ago

India IT Set For Fourth Year of Weak Growth on Geopolitics, AI Risks

Bloomberg · Markets 49m ago

Gold Rises, Supported by Potential China Demand

Dow Jones · Markets 49m ago

Is a Berkshire Hathaway Class A Stock Split Finally Coming?

NASDAQ · Markets 50m ago

SoftBank shares slide as OpenAI revenue report dents AI optimism

Investing.com · Investing_news 53m ago